These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 32223973)

  • 1. The evaluation of thiol-disulfıte balance, ischemıa albumın modıfıcation and seruloplazmine as a new oxidatıve stress in mild cognitive impairment and early stage alzheimer's disease patients.
    Gündüztepe Y; Bukan N; Zorlu E; Karaman Y; Andaç Topkan T; Gurbuz N; Neşelioğlu S; Erel Ö
    J Clin Neurosci; 2020 May; 75():188-194. PubMed ID: 32223973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel oxidative stress marker in patients with Alzheimer's disease: dynamic thiol-disulphide homeostasis.
    Gumusyayla S; Vural G; Bektas H; Deniz O; Neselioglu S; Erel O
    Acta Neuropsychiatr; 2016 Dec; 28(6):315-320. PubMed ID: 27040443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ischaemia-modified albumin might be a potential biomarker for oxidative stress in amnestic mild cognitive impairment.
    Du L; Ma J; He D; Zhang X
    Psychogeriatrics; 2019 Mar; 19(2):150-156. PubMed ID: 30362220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
    Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
    J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiol-Disulfide Homeostasis and Serum Ischemia Modified Albumin Levels in Patients with Primary Open-Angle Glaucoma.
    Karakurt Y; Mertoglu C; Gok G; Ucak T; Tasli N; Icel E; Erel O
    Curr Eye Res; 2019 Aug; 44(8):896-900. PubMed ID: 30868923
    [No Abstract]   [Full Text] [Related]  

  • 7. Thiol-disulfide homeostasis and ischemia-modified albumin as a marker of oxidative stress in patients with sarcopenia.
    Özsürekci C; Şengül Ayçiçek G; Çalışkan H; Tuna Doğrul R; Neşelioğlu S; Özcan M; Doğu BB; Cankurtaran M; Erel Ö; Halil MG
    Geriatr Gerontol Int; 2021 Jul; 21(7):584-589. PubMed ID: 34080286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease.
    Altunoglu E; Guntas G; Erdenen F; Akkaya E; Topac I; Irmak H; Derici H; Yavuzer H; Gelisgen R; Uzun H
    Geriatr Gerontol Int; 2015 Jul; 15(7):872-80. PubMed ID: 25345484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis.
    Schrag M; Mueller C; Zabel M; Crofton A; Kirsch WM; Ghribi O; Squitti R; Perry G
    Neurobiol Dis; 2013 Nov; 59():100-10. PubMed ID: 23867235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics based identification of differential plasma proteins and changes in white matter integrity as markers in early detection of mild cognitive impaired subjects at high risk of Alzheimer's disease.
    Kumar A; Singh S; Verma A; Mishra VN
    Neurosci Lett; 2018 May; 676():71-77. PubMed ID: 29649488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiol-Disulfide Homeostasis, Serum Ferroxidase Activity, and Serum Ischemia Modified Albumin Levels in Neonatal Jaundice.
    Topal I; Mertoglu C; Surucu Kara I; Siranli G; Gok G; Erel Ö
    Fetal Pediatr Pathol; 2019 Apr; 38(2):138-145. PubMed ID: 30741063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of Cognitive Impairment Compatible with Early Diagnosis of Alzheimer's Disease. A Bayesian Network Model based on the Analysis of Oral Definitions of Semantic Categories.
    Guerrero JM; Martínez-Tomás R; Rincón M; Peraita H
    Methods Inf Med; 2016; 55(1):42-9. PubMed ID: 25925692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline?
    Ye BS; Lee WW; Ham JH; Lee JJ; Lee PH; Sohn YH;
    Eur J Neurol; 2016 May; 23(5):948-57. PubMed ID: 26917248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemia modified albumin and plasma oxidative stress markers in Alzheimer's disease.
    Can M; Varlibas F; Guven B; Akhan O; Yuksel GA
    Eur Neurol; 2013; 69(6):377-80. PubMed ID: 23751563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study.
    Costa AC; Joaquim HPG; Forlenza OV; Gattaz WF; Talib LL
    Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):483-488. PubMed ID: 31218445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D Increases Aβ140 Plasma Levels and Protects Lymphocytes from Oxidative Death in Mild Cognitive Impairment Patients.
    SanMartin CD; Henriquez M; Chacon C; Ponce DP; Salech F; Rogers NK; Behrens MI
    Curr Alzheimer Res; 2018; 15(6):561-569. PubMed ID: 29283046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of thiol-disulfide homeostasis and ischemia-modified albumin in osteosarcopenia.
    Ileri I; Eren F; Neselioglu S; Hafızoglu M; Karaduman D; Atbas C; Sahiner Z; Dikmeer A; Balcı C; Dogu BB; Cankurtaran M; Erel O; Halil MG
    Ir J Med Sci; 2024 Aug; 193(4):2109-2114. PubMed ID: 38512402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease.
    Olazarán J; Gil-de-Gómez L; Rodríguez-Martín A; Valentí-Soler M; Frades-Payo B; Marín-Muñoz J; Antúnez C; Frank-García A; Acedo-Jiménez C; Morlán-Gracia L; Petidier-Torregrossa R; Guisasola MC; Bermejo-Pareja F; Sánchez-Ferro Á; Pérez-Martínez DA; Manzano-Palomo S; Farquhar R; Rábano A; Calero M
    J Alzheimers Dis; 2015; 45(4):1157-73. PubMed ID: 25649659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.